About Peter Collins

A seasoned executive in the medical diagnostics, life sciences and pharmaceutical sector. Key commercial strengths in leadership,business development and strategy have enabled significant contributions to a number of early stage Dx companies and delivery on their high growth potential. Team orientated, comfortable both leading and influencing change within the exec team.

Specialties: Personalized medicine and Dx/Rx co-development. Widely experienced in the key activities and challenges that face both Dx and RX when collaborating on regulatory approval and post approval commercialization activities globally.